The United States remains a dominant force in top-cited nursing oncology publications with a 43.02% share in 2023, albeit with a modest 2.57% year-on-year growth. China and the UK show significant potential with 10.05% and 14.19% growth respectively, reflecting increased research output in these regions. Canada's 4.57% decline indicates a need for revitalization. Notably, Switzerland and Belgium exhibit remarkable growth surges at 103.36% and 134.09%, suggesting emergent research excellence.
Future trends to watch include sustained progress from developing countries like India and South Korea, as they continue to increase their global academic influence through substantial year-on-year gains. Adaptation to advanced research methods and international collaboration will further diversify top-cited contributions in this field globally.
Top countries in Total Number of 10% Top-Cited Scientific Publications in Nursing Oncology Share by Country (Units (Publications))
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 43.02 | 2023 | +4.49% | +2.57% | View data |
| 2 | 2 China | 8.93 | 2023 | +7.56% | +10.05% | View data |
| 3 | 3 United Kingdom | 8.78 | 2023 | +3.25% | +14.19% | View data |
| 4 | 4 Australia | 7.12 | 2023 | +5.15% | +17.58% | View data |
| 5 | 5 Canada | 4.58 | 2023 | +0.066% | -4.57% | View data |
| 6 | 6 Netherlands | 4.36 | 2023 | +5.24% | +4.15% | View data |
| 7 | 7 India | 4.24 | 2023 | +6.6% | +13.15% | View data |
| 8 | 8 South Korea | 2.12 | 2023 | +1.23% | +22.63% | View data |
| 9 | 9 Spain | 2.05 | 2023 | +20.36% | +6.06% | View data |
| 10 | 10 Germany | 1.86 | 2023 | +6.56% | +4.01% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
